27^th European Diabetes Congress June 20-21, 2018 | Rome, Italy

Conference Series takes immense pleasure to extend our warm welcome to you all to 27^th European Diabetes Congress which will be happening in Rome, Italy from June 20-21, 2018 with the theme " New technologies and practical approaches in the field of diabetes and endocrine disorders".

Sessions:

Track-01: Diabetes Research in Clinical Practice

Diabetes may be a common chronic illness that imposes right smart demands on the individual tending system. Individuals with polygenic disease have the next rate of disorder than those while not diabetes and are at multiplied risk for renal disorder, lower limb amputation and vision defect. Novel remedial targets accessible for diabetes incorporates Incretion based treatments, oral helpful operators like secretagogues, beta cell recovery and expansion and foundational microorganism treatments. Undeveloped Embryonic cell and fetal antecedent cell transplantationtreatments are the significant undifferentiated cell treatments accessible for Diabetes. Aside from the above, different computational methodologies in Diabetes administration control have been presented as of late which are assuming an imperative part in recognizable proof of qualities bringing about diabetes helping in Early Detection of Diabetes. These procedures are likewise valuable in concentrating on the compound etiologist of Diabetes revealing different treatment prospects and model development forms for survival expectation. The global diabetes research market is projected to reach USD 10.58 billion by 2022 from an estimated USD 8.35 billion in 2017, at a CAGR of 4.8% during the forecast period.

Recommended: Diabetes Conferences | Endocrinology Conferences | Diabetes Meetings

3^rd Metabolic Syndrome Conferences June 18-19, 2018 Dublin, Ireland; 29^th Prevention of Diabetes and Complications Conferences September 27-28, 2018 Berlin, Germany; 3^rd Public Health and Nutrition Conferences February 26-28, 2018 London, UK; 4^th Health Economics, Health Policy and Health care Management September 13-14, 2018 Zurich, Switzerland; 13^th Healthcare & Technologies Conferences June 14-15, 2018 Dublin, Ireland; 2^nd Patient Safety and Quality Healthcare June 21-22, 2018 Dublin, Ireland; 6^th Medical Informatics and Telemedicine Conferences July 5-6, 2018 Berlin, Germany; 3^rd Environmental Health Conferences October 15-16, 2018 Warsaw, Poland

Related Societies:

USA: American Association of Diabetes Educators | American Diabetes Association | Canadian Diabetes Association | American Association for Clinical Endocrinology | Diabetes Canada

Europe: European Society of Endocrinology | Central European Diabetes Association | FAND - Italian Association of Diabetics | Italian Association for the Defence of the Interests of Diabetics | International Diabetes Federation- Italy

Asia-Pacific: Australian Diabetes Society | Asian Association for the Study of Diabetes | Diabetes Association of Nigeria | Diabetes Association of the Republic of China | Asian Diabetic Association

Track-02: Diabetes mellitus type 1

Diabetes mellitus type 1 (otherwise called type 1 diabetes) is a type of diabetes mellitus that outcomes from the immune system annihilation of the insulin-delivering beta cells in the pancreas. The ensuing absence of insulin prompts expanded glucose in the blood and pee. The established manifestations are regular pee, expanded thirst, expanded yearning, and weight reduction. The reason for diabetes mellitus sort 1 is obscure. Type 1 diabetes can be recognized from type 2 from autoantibody testing. The C-peptide test, which measures endogenous insulin generation, can likewise be utilized.

Organization of insulin is fundamental for survival. Insulin treatment must be proceeded with uncertainly and commonly does not disable ordinary every day exercises. Individuals are normally prepared to freely deal with their diabetes; be that as it may, for some this can challenge. Untreated, diabetes can bring about numerous confusions. Intense confusions incorporate diabetic ketoacidosis and nonketotic hyperosmolar trance like state. Genuine long haul complexities identified with high glucose incorporate coronary illness, stroke, kidney disappointment, foot ulcers and harm to the eyes. Moreover, confusions may emerge from low glucose brought about by exorbitant insulin treatment. Diabetes mellitus type 1 represents around 5% and 10% of all diabetes cases. 

Diabetes Mellitus has been growing at an exponential rate and World Health Organization (WHO) estimates that the diabetic population is likely to reach 366 million in 2030. The United States is expected to have an increase of 102 per cent in the diabetic epidemic in 2030 when compared to 2000

Recommended: Diabetes Conferences | Endocrinology Conferences | Diabetes Meetings

3^rd Metabolic Syndrome Conferences June 18-19, 2018 Dublin, Ireland; 29^th Prevention of Diabetes and Complications Conferences September 27-28, 2018 Berlin, Germany; 3^rd Public Health and Nutrition Conferences February 26-28, 2018 London, UK; 4^th Health Economics, Health Policy and Health care Management September 13-14, 2018 Zurich, Switzerland; 13^th Healthcare & Technologies Conferences June 14-15, 2018 Dublin, Ireland; 2^nd Patient Safety and Quality Healthcare June 21-22, 2018 Dublin, Ireland; 6^th Medical Informatics and Telemedicine Conferences July 5-6, 2018 Berlin, Germany; 3^rd Environmental Health Conferences October 15-16, 2018 Warsaw, Poland

Related Societies:

USA: American Association of Diabetes Educators | American Diabetes Association | Canadian Diabetes Association | American Association for Clinical Endocrinology | Diabetes Canada

Europe: European Society of Endocrinology | Central European Diabetes Association | FAND - Italian Association of Diabetics | Italian Association for the Defence of the Interests of Diabetics | International Diabetes Federation- Italy

Asia-Pacific: Australian Diabetes Society | Asian Association for the Study of Diabetes | Diabetes Association of Nigeria | Diabetes Association of the Republic of China | Asian Diabetic Association

Track-03: Diabetes mellitus type 2

Type 2 diabetes is a long haul metabolic turmoil that is portrayed by high glucose, insulin resistance, and relative absence of insulin. Basic side effects incorporate expanded thirst, incessant pee, and unexplained weight reduction. Indications may likewise incorporate expanded craving, feeling tired, and bruises that don't recuperate. Regularly indications go ahead gradually. Long haul complexities from high glucose incorporate coronary illness, strokes, diabetic retinopathy which can bring about visual impairment, kidney disappointment, and poor blood stream in the appendages which may prompt removals. The sudden onset of hyperosmolar hyperglycaemic state may happen; in any case, diabetic ketoacidosis is unprecedented. Type 2 diabetes is mostly preventable by staying a typical weight, practicing consistently, and eating legitimately. Treatment includes activity and dietary changes. In the event that glucose levels are not sufficiently brought down, the medicine metformin is regularly suggested. Numerous individuals may in the end likewise require insulin infusions. In that on insulin, routinely check glucose levels is exhorted, in any case this may not be required in those taking pills. Bariatric surgery frequently enhances diabetes in the individuals who are stout. Diabetes mellitus is a devastating and complex metabolic disease, expected to affect over 500 million people worldwide by the year 2030; up from 350 million in 2010. Approximately 95% of patients suffer from type 2 diabetes, and its prevalence is expected to increase in the future.

Recommended: Diabetes Conferences | Endocrinology Conferences | Diabetes Meetings

3^rd Metabolic Syndrome Conferences June 18-19, 2018 Dublin, Ireland; 29^th Prevention of Diabetes and Complications Conferences September 27-28, 2018 Berlin, Germany; 3^rd Public Health and Nutrition Conferences February 26-28, 2018 London, UK; 4^th Health Economics, Health Policy and Health care Management September 13-14, 2018 Zurich, Switzerland; 13^th Healthcare & Technologies Conferences June 14-15, 2018 Dublin, Ireland; 2^nd Patient Safety and Quality Healthcare June 21-22, 2018 Dublin, Ireland; 6^th Medical Informatics and Telemedicine Conferences July 5-6, 2018 Berlin, Germany; 3^rd Environmental Health Conferences October 15-16, 2018 Warsaw, Poland

Related Societies:

USA: American Association of Diabetes Educators | American Diabetes Association | Canadian Diabetes Association | American Association for Clinical Endocrinology | Diabetes Canada

Europe: European Society of Endocrinology | Central European Diabetes Association | FAND - Italian Association of Diabetics | Italian Association for the Defence of the Interests of Diabetics | International Diabetes Federation- Italy

Asia-Pacific: Australian Diabetes Society | Asian Association for the Study of Diabetes | Diabetes Association of Nigeria | Diabetes Association of the Republic of China | Asian Diabetic Association

Track-04: Diabetic Disorders and Treatment

Diabetes, frequently referred to by specialists as diabetes mellitus, depicts a gathering of diabetes and metabolic sicknesses in which the individual has high blood (glucose), either in light of the fact that insulin generation is lacking, or on the grounds that the body's phones don't react appropriately to insulin, or both. Patients with high glucose will normally encounter polyuria (continuous pee), they will turn out to be progressively parched (polydipsia) and hungry (polyphagia). Recognizing type 1 and type 2 diabetes at determination is critical. Average qualities of type 2 diabetes incorporate the, Slow and guileful onset, most normal in overweight or fat patients from a minority bunch (Native Americans, blacks, and Pacific Islanders), Signs of insulin resistance, Strong family history of type 2 diabetes. Familial way of life danger components prompting heftiness might be available, as may a family history of cardiovascular disease or metabolic disorder. Pediatric Diabetes is a type 1 diabetes mellitus requires insulin treatment. The number of people living with diabetes in Europe is expected to increase from 52 million in 2014 to 68.9 million by 2035, according to the International Diabetes Federation (IDF). Across Europe, around 1 in 11 adults is affected and this number is set to rise as the population ages.

Recommended: Diabetes Conferences | Endocrinology Conferences | Diabetes Meetings

3^rd Metabolic Syndrome Conferences June 18-19, 2018 Dublin, Ireland; 29^th Prevention of Diabetes and Complications Conferences September 27-28, 2018 Berlin, Germany; 3^rd Public Health and Nutrition Conferences February 26-28, 2018 London, UK; 4^th Health Economics, Health Policy and Health care Management September 13-14, 2018 Zurich, Switzerland; 13^th Healthcare & Technologies Conferences June 14-15, 2018 Dublin, Ireland; 2^nd Patient Safety and Quality Healthcare June 21-22, 2018 Dublin, Ireland; 6^th Medical Informatics and Telemedicine Conferences July 5-6, 2018 Berlin, Germany; 3^rd Environmental Health Conferences October 15-16, 2018 Warsaw, Poland

Related Societies:

USA: American Association of Diabetes Educators | American Diabetes Association | Canadian Diabetes Association | American Association for Clinical Endocrinology | Diabetes Canada

Europe: European Society of Endocrinology | Central European Diabetes Association | FAND - Italian Association of Diabetics | Italian Association for the Defence of the Interests of Diabetics | International Diabetes Federation- Italy

Asia-Pacific: Australian Diabetes Society | Asian Association for the Study of Diabetes | Diabetes Association of Nigeria | Diabetes Association of the Republic of China | Asian Diabetic Association

Track-05: Diabetes Advanced Technologies

The concept of 'new innovations' for type 1 diabetes and new revelation and propelled type 2 diabetes treatment has extended as of late at a rate that some should seriously think about similar to 'Moore's Law', and the sheer number of new advancements going into the type 1 diabetes commercial centre is likewise developing at a surprising rate. From the patient's viewpoint, this is energizing as well as can prompt a feeling of positive thinking. Advancements that today are developing typical (e.g. insulin pumps, fast HbA1c observing, and so forth go under new remedial instruments of diabetes. Without a doubt, it could be contended that the real advances in type 1 diabetes care made inside the last quarter of a century have originated from innovation instead of science. In the meantime, not all new innovations succeed (e.g. the Glucowatch), paying little respect to their implied guarantee. Both type 1 diabetes patients and their medicinal services suppliers will soon see a progression of further propelled therapeutic advancements utilized as a part of doctor's facility and new innovations and novel treatments in diabetes treatment whose premise is fixing to the idea of enhancing the lives of those with the malady. The Asia-Pacific Diabetes Care Devices Market has been estimated at USD 2.461 Billion in 2015 and is projected to reach USD 3.518 billion by 2020, at a CAGR of 7.41% during the forecast period from 2015 to 2020.

Recommended: Diabetes Conferences | Endocrinology Conferences | Diabetes Meetings

3^rd Metabolic Syndrome Conferences June 18-19, 2018 Dublin, Ireland; 29^th Prevention of Diabetes and Complications Conferences September 27-28, 2018 Berlin, Germany; 3^rd Public Health and Nutrition Conferences February 26-28, 2018 London, UK; 4^th Health Economics, Health Policy and Health care Management September 13-14, 2018 Zurich, Switzerland; 13^th Healthcare & Technologies Conferences June 14-15, 2018 Dublin, Ireland; 2^nd Patient Safety and Quality Healthcare June 21-22, 2018 Dublin, Ireland; 6^th Medical Informatics and Telemedicine Conferences July 5-6, 2018 Berlin, Germany; 3^rd Environmental Health Conferences October 15-16, 2018 Warsaw, Poland

Related Societies:

USA: American Association of Diabetes Educators | American Diabetes Association | Canadian Diabetes Association | American Association for Clinical Endocrinology | Diabetes Canada

Europe: European Society of Endocrinology | Central European Diabetes Association | FAND - Italian Association of Diabetics | Italian Association for the Defence of the Interests of Diabetics | International Diabetes Federation- Italy

Asia-Pacific: Australian Diabetes Society | Asian Association for the Study of Diabetes | Diabetes Association of Nigeria | Diabetes Association of the Republic of China | Asian Diabetic Association

Track-06: Gestational Diabetes

Gestational diabetes is first analysed amid pregnancy. Like type 1 and type 2 diabetes, gestational diabetes causes glucose levels to wind up noticeably too high. When you eat, your stomach related framework separates the greater part of the sustenance into a sugar called glucose. It's the point at which the blood glucose level (glucose level) of the mother goes too high amid pregnancy. Gestational diabetes creates when your body can't deliver enough of the hormone insulin amid pregnancy. Insulin is important to transport glucose what your body utilizes for vitality into the cells. Without enough insulin, you can develop excessively glucose in your blood, prompting a higher-than-typical blood glucose level and maybe gestational diabetes. The higher blood glucose level in gestational diabetes caused by hormones discharged by the placenta amid pregnancy. The placenta delivers a hormone called the human placental lactogen (HPL), otherwise called human chorionic somatomammotropic (HCS). According to the International Diabetes Federation in 2016, it was estimated that 420 million adult population is suffering from diabetes which is increasing at the rate of 8.4% and is expected to reach 625 million by 2040. According to the American Pregnancy Association, approximately 2-5% of pregnant women develop gestational diabetes; this number may increase to 7-9% of mothers who are more likely to have risk factors.

Recommended: Diabetes Conferences | Endocrinology Conferences | Diabetes Meetings

3^rd Metabolic Syndrome Conferences June 18-19, 2018 Dublin, Ireland; 29^th Prevention of Diabetes and Complications Conferences September 27-28, 2018 Berlin, Germany; 3^rd Public Health and Nutrition Conferences February 26-28, 2018 London, UK; 4^th Health Economics, Health Policy and Health care Management September 13-14, 2018 Zurich, Switzerland; 13^th Healthcare & Technologies Conferences June 14-15, 2018 Dublin, Ireland; 2^nd Patient Safety and Quality Healthcare June 21-22, 2018 Dublin, Ireland; 6^th Medical Informatics and Telemedicine Conferences July 5-6, 2018 Berlin, Germany; 3^rd Environmental Health Conferences October 15-16, 2018 Warsaw, Poland

Related Societies:

USA: American Association of Diabetes Educators | American Diabetes Association | Canadian Diabetes Association | American Association for Clinical Endocrinology | Diabetes Canada

Europe: European Society of Endocrinology | Central European Diabetes Association | FAND - Italian Association of Diabetics | Italian Association for the Defence of the Interests of Diabetics | International Diabetes Federation- Italy

Asia-Pacific: Australian Diabetes Society | Asian Association for the Study of Diabetes | Diabetes Association of Nigeria | Diabetes Association of the Republic of China | Asian Diabetic Association

Track- 07: Stem Cell treatment in Diabetes

Stem cells use in islet cell transplants to cure type 1 diabetes, stem cell replacement should be more than just an instance of swapping insulin-delivering cells from a healthy pancreas with those annihilated by diabetes in a diabetic patient. It is conceivable to treat Type 1 diabetes by transplanting confined islet cells, containing beta cells or even an entire pancreas into the patient from a contributor. Transplants can empower the body to recover control of glucose levels so administrating insulin is never again required. Pancreatic stem cell islets, additionally called islets of Langerhans, are modest groups of cells scattered all through the pancreas. Pancreatic islets contain a few types of cells, including beta cells that create the hormone insulin. Insulin enables cells all through the body to retain glucose from the circulation system and utilize it for vitality.

The global stem cell market is expected to reach USD 15.63billion by 2025, growing at a CAGR of 9.2%, according to a new report by Grand View Research, Inc. Augmentation in research studies that aim at broadening the utility scope of associated products is anticipated to drive the market growth. These research projects have opened the possibility of implementation of several clinical applications of these cells, thereby impacting disease-modifying treatments.

Recommended: Diabetes Conferences | Endocrinology Conferences | Diabetes Meetings

3^rd Metabolic Syndrome Conferences June 18-19, 2018 Dublin, Ireland; 29^th Prevention of Diabetes and Complications Conferences September 27-28, 2018 Berlin, Germany; 3^rd Public Health and Nutrition Conferences February 26-28, 2018 London, UK; 4^th Health Economics, Health Policy and Health care Management September 13-14, 2018 Zurich, Switzerland; 13^th Healthcare & Technologies Conferences June 14-15, 2018 Dublin, Ireland; 2^nd Patient Safety and Quality Healthcare June 21-22, 2018 Dublin, Ireland; 6^th Medical Informatics and Telemedicine Conferences July 5-6, 2018 Berlin, Germany; 3^rd Environmental Health Conferences October 15-16, 2018 Warsaw, Poland

Related Societies:

USA: American Association of Diabetes Educators | American Diabetes Association | Canadian Diabetes Association | American Association for Clinical Endocrinology | Diabetes Canada

Europe: European Society of Endocrinology | Central European Diabetes Association | FAND - Italian Association of Diabetics | Italian Association for the Defence of the Interests of Diabetics | International Diabetes Federation- Italy

Asia-Pacific: Australian Diabetes Society | Asian Association for the Study of Diabetes | Diabetes Association of Nigeria | Diabetes Association of the Republic of China | Asian Diabetic Association

Track-08: Diabetes Ophthalmology

Diabetic retinopathy is the most common diabetic eye disease and a leading cause of blindness in adults in the U.S. It is caused by changes in the blood vessels of the retina. The retina is the light-sensitive tissue at the back of the eye. A healthy retina is necessary for good vision. Diabetic retinopathy can be detected during a dilated eye exam by an ophthalmologist or optometrist. An exam by your primary doctor, during which your eyes are not dilated, is not an adequate substitute for a full exam done by an ophthalmologist. Eye exams for people with diabetes can include: Visual acuity testing. Diabetic retinopathy affects blood vessels in the light-sensitive tissue called the retina that lines the back of the eye. It is the most common cause of vision loss among people with diabetes and the leading cause of vision impairment and blindness among working-age adults.

Diabetes can harm your eyes. It can damage the small blood vessels in your retina, or the back of your eye. This condition is called diabetic retinopathy. Diabetes also increases your risk of glaucoma and other eye problems. There is no cure for diabetic retinopathy. But laser treatment photocoagulation is usually very effective at preventing vision loss if it is done before the retina has been severely damaged. Surgical removal of the vitreous gel (vitrectomy) may also help improve vision if the retina has not been severely damaged. Diabetic Retinopathy Market was valued at $966 million in 2015, and is expected to reach $2,490 million by 2022, supported by a CAGR of 14.4% during the forecast period 2014 to 2022.

Recommended: Diabetes Conferences | Endocrinology Conferences | Diabetes Meetings

3^rd Metabolic Syndrome Conferences June 18-19, 2018 Dublin, Ireland; 29^th Prevention of Diabetes and Complications Conferences September 27-28, 2018 Berlin, Germany; 3^rd Public Health and Nutrition Conferences February 26-28, 2018 London, UK; 4^th Health Economics, Health Policy and Health care Management September 13-14, 2018 Zurich, Switzerland; 13^th Healthcare & Technologies Conferences June 14-15, 2018 Dublin, Ireland; 2^nd Patient Safety and Quality Healthcare June 21-22, 2018 Dublin, Ireland; 6^th Medical Informatics and Telemedicine Conferences July 5-6, 2018 Berlin, Germany; 3^rd Environmental Health Conferences October 15-16, 2018 Warsaw, Poland

Related Societies:

USA: American Association of Diabetes Educators | American Diabetes Association | Canadian Diabetes Association | American Association for Clinical Endocrinology | Diabetes Canada

Europe: European Society of Endocrinology | Central European Diabetes Association | FAND - Italian Association of Diabetics | Italian Association for the Defence of the Interests of Diabetics | International Diabetes Federation- Italy

Asia-Pacific: Australian Diabetes Society | Asian Association for the Study of Diabetes | Diabetes Association of Nigeria | Diabetes Association of the Republic of China | Asian Diabetic Association

Track-09: Endocrinology & Diabetes: Diseases & Disorders

The Endocrine system controls the stream of information among cells and tissues, represented by complex managerial parts. Hormones apply in all cases impacts on various metabolic methods which ensure regulatory, change genic and integrative limit. Signs and indications of endocrine issue navigate the entire clinical range. The Endocrine system is a system of organs that create and discharge hormones that assistance controls numerous imperative body capacities, including the body's capacity to change calories into energy that forces cells and organs. The Endocrine system impacts how your heart beats, how your bones and tissues develop, even your capacity to make a child. It assumes a key part in regardless of whether you create diabetes, thyroid sickness, development issue, sexual brokenness, and a large group of other hormone-related disorders. Endocrine disease that outcomes when an organ delivers excessively or too little of an endocrine hormone, called a hormone imbalance. Endocrine disease is because of the improvement of injuries, (for example, knobs or tumours) in the endocrine system, which might influence hormone levels. Endocrine disorders might be symptomless or sufficiently gentle to not require treatment. Surgery or radiation treatment might be utilized. Regularly, finding and treatment of the hidden reason for the endocrine issue will resolve the symptoms.

Recommended: Diabetes Conferences | Endocrinology Conferences | Diabetes Meetings

3^rd Metabolic Syndrome Conferences June 18-19, 2018 Dublin, Ireland; 29^th Prevention of Diabetes and Complications Conferences September 27-28, 2018 Berlin, Germany; 3^rd Public Health and Nutrition Conferences February 26-28, 2018 London, UK; 4^th Health Economics, Health Policy and Health care Management September 13-14, 2018 Zurich, Switzerland; 13^th Healthcare & Technologies Conferences June 14-15, 2018 Dublin, Ireland; 2^nd Patient Safety and Quality Healthcare June 21-22, 2018 Dublin, Ireland; 6^th Medical Informatics and Telemedicine Conferences July 5-6, 2018 Berlin, Germany; 3^rd Environmental Health Conferences October 15-16, 2018 Warsaw, Poland

Related Societies:

USA: American Association of Diabetes Educators | American Diabetes Association | Canadian Diabetes Association | American Association for Clinical Endocrinology | Diabetes Canada

Europe: European Society of Endocrinology | Central European Diabetes Association | FAND - Italian Association of Diabetics | Italian Association for the Defence of the Interests of Diabetics | International Diabetes Federation- Italy

Asia-Pacific: Australian Diabetes Society | Asian Association for the Study of Diabetes | Diabetes Association of Nigeria | Diabetes Association of the Republic of China | Asian Diabetic Association

Track-10: Thyroid Disorders in Children, Teens and Adolescents

Thyroid issues are not uncommon in youngsters, but rather they are not as regular as guardians. Hyperthyroidism an overactive thyroid organ is seen just once in a while in new-borns. This condition is alluded to as neonatal hyperthyroidism. Although thyroid ailment happens less much of the time in kids than in grown-ups, the signs and indications can be comparable. In any case, there are a couple of essential contrasts that should be conveyed to light. Inborn hypothyroidism is a confusion that influences Newborn children during childbirth, and happens in around 1 in 4000 live-conceived babies. It is portrayed by the loss of thyroid capacity, because of the thyroid organ neglecting to grow regularly. At times, the organ is totally absent. Around 10% of cases are brought on by a catalyst deformity prompting inadequate hormones generation, iodine lack and a cerebrum pituitary organ variation from the norm. On the off chance that the determination is postponed, and quick treatment is not given, innate hypothyroidism can prompt development and formative imperfections, and serious mental impediment (cretinism).

The global thyroid gland disorders treatment market is likely to exhibit a 3.1% CAGR between 2015 and 2023. The market is expected to be worth US$2,414.6 mn by the end 2023 from a valuation of US$1,806.2 mn in 2014.

Recommended: Diabetes Conferences | Endocrinology Conferences | Diabetes Meetings

3^rd Metabolic Syndrome Conferences June 18-19, 2018 Dublin, Ireland; 29^th Prevention of Diabetes and Complications Conferences September 27-28, 2018 Berlin, Germany; 3^rd Public Health and Nutrition Conferences February 26-28, 2018 London, UK; 4^th Health Economics, Health Policy and Health care Management September 13-14, 2018 Zurich, Switzerland; 13^th Healthcare & Technologies Conferences June 14-15, 2018 Dublin, Ireland; 2^nd Patient Safety and Quality Healthcare June 21-22, 2018 Dublin, Ireland; 6^th Medical Informatics and Telemedicine Conferences July 5-6, 2018 Berlin, Germany; 3^rd Environmental Health Conferences October 15-16, 2018 Warsaw, Poland

Related Societies:

USA: American Association of Diabetes Educators | American Diabetes Association | Canadian Diabetes Association | American Association for Clinical Endocrinology | Diabetes Canada

Europe: European Society of Endocrinology | Central European Diabetes Association | FAND - Italian Association of Diabetics | Italian Association for the Defence of the Interests of Diabetics | International Diabetes Federation- Italy

Asia-Pacific: Australian Diabetes Society | Asian Association for the Study of Diabetes | Diabetes Association of Nigeria | Diabetes Association of the Republic of China | Asian Diabetic Association

Track-11: Advances in Endocrinology Metabolism

Treat patients with hyperparathyroidism, Address particular issues of Graves' disease including thyrocardiac ailment, ophthalmopathy, dermopathy, delayed pregnancy, mammary, Use the 2015 ATA rules in the administration of their patients with thyroid knobs and thyroid malignancy determination, Determine when to do atomic hereditary disease testing amid assessment of a thyroid knob, Identify the ordinarily experienced adrenal and pituitary issue (clinical cases), Counsel patients on ripeness issues while being dealt with for growth, Provide the best treatment for transgender patients, Use the new lipid bringing operators and how down to oversee quiet who can't take statins. Intrinsic adrenal hyperplasia (CAH) are any of a few autosomal latent sicknesses coming about because of changes of qualities for catalysts intervening the biochemical strides of creation of mineralocorticoids, glucocorticoids or sex steroids from cholesterol by the endocrine organs (steroid beginning).

Recommended: Diabetes Conferences | Endocrinology Conferences | Diabetes Meetings

3^rd Metabolic Syndrome Conferences June 18-19, 2018 Dublin, Ireland; 29^th Prevention of Diabetes and Complications Conferences September 27-28, 2018 Berlin, Germany; 3^rd Public Health and Nutrition Conferences February 26-28, 2018 London, UK; 4^th Health Economics, Health Policy and Health care Management September 13-14, 2018 Zurich, Switzerland; 13^th Healthcare & Technologies Conferences June 14-15, 2018 Dublin, Ireland; 2^nd Patient Safety and Quality Healthcare June 21-22, 2018 Dublin, Ireland; 6^th Medical Informatics and Telemedicine Conferences July 5-6, 2018 Berlin, Germany; 3^rd Environmental Health Conferences October 15-16, 2018 Warsaw, Poland

Related Societies:

USA: American Association of Diabetes Educators | American Diabetes Association | Canadian Diabetes Association | American Association for Clinical Endocrinology | Diabetes Canada

Europe: European Society of Endocrinology | Central European Diabetes Association | FAND - Italian Association of Diabetics | Italian Association for the Defence of the Interests of Diabetics | International Diabetes Federation- Italy

Asia-Pacific: Australian Diabetes Society | Asian Association for the Study of Diabetes | Diabetes Association of Nigeria | Diabetes Association of the Republic of China | Asian Diabetic Association

Track-12: Treatment and Diagnosis of Endocrine Diseases

Endocrine organs, they are the hormones creating organs in the body, and the regular ones are thyroid, parathyroid hormones, pancreas and adrenal organs. On the off chance that the thyroid endocrinology is making additional prohormones, a patient will have manifestations like uneasiness, tremors, sweating, palpitations, or trouble nodding off. At first, this is made do with prescription, or there are pills like radioactive iodine that can wreck the thyroid organ. Endocrine disruptors are chemicals that, at specific measurements, can meddle with the endocrine (or hormone) framework in warm blooded animals. These interruptions can bring about carcinogenic mind tumours, birth abscond, and other formative issue. Addison's illness (likewise Addison infection, incessant adrenal deficiency, hypocortisolism, and hypoadrenalism) is an uncommon, ceaseless endocrine framework issue in which the adrenal organs don't create adequate steroid hormones (glucocorticoids and mineralocorticoids).

Recommended: Diabetes Conferences | Endocrinology Conferences | Diabetes Meetings

3^rd Metabolic Syndrome Conferences June 18-19, 2018 Dublin, Ireland; 29^th Prevention of Diabetes and Complications Conferences September 27-28, 2018 Berlin, Germany; 3^rd Public Health and Nutrition Conferences February 26-28, 2018 London, UK; 4^th Health Economics, Health Policy and Health care Management September 13-14, 2018 Zurich, Switzerland; 13^th Healthcare & Technologies Conferences June 14-15, 2018 Dublin, Ireland; 2^nd Patient Safety and Quality Healthcare June 21-22, 2018 Dublin, Ireland; 6^th Medical Informatics and Telemedicine Conferences July 5-6, 2018 Berlin, Germany; 3^rd Environmental Health Conferences October 15-16, 2018 Warsaw, Poland

Related Societies:

USA: American Association of Diabetes Educators | American Diabetes Association | Canadian Diabetes Association | American Association for Clinical Endocrinology | Diabetes Canada

Europe: European Society of Endocrinology | Central European Diabetes Association | FAND - Italian Association of Diabetics | Italian Association for the Defence of the Interests of Diabetics | International Diabetes Federation- Italy

Asia-Pacific: Australian Diabetes Society | Asian Association for the Study of Diabetes | Diabetes Association of Nigeria | Diabetes Association of the Republic of China | Asian Diabetic Association

Track- 13: Ketogenic Diet for Diabetes

A Ketogenic diet may be a very low-carb diet, considered to be once you eat a level of sugar of around 30g of carbohydrates per day or below. This encourages the body to induce its energy from burning body fat that produces AN energy supply called ketones. The diet helps to lower the body's demand for hypoglycemic agent that has advantages for individuals with type one and type two diabetes. Note that it's necessary that you just speak to your doctor if you're considering following the diet as precautions might have to be taken before beginning. On a Ketogenic diet, blood sugar levels area unit unbroken at a low however healthy level which encourages the body to interrupt down fat into a fuel supply called ketones. The method of breaking down or ‘burning’ body fat is known as ketosis. People on hypoglycemic agent can generally need smaller doses of hypoglycemic agent that results in less risk of huge dosing errors. The diet helps burn body fat and therefore, has specific benefits for those trying to reduce weight, as well as people with prediabetes, or those otherwise, in danger of type two diabetes.

Recommended: Diabetes Conferences | Endocrinology Conferences | Diabetes Meetings

3^rd Metabolic Syndrome Conferences June 18-19, 2018 Dublin, Ireland; 29^th Prevention of Diabetes and Complications Conferences September 27-28, 2018 Berlin, Germany; 3^rd Public Health and Nutrition Conferences February 26-28, 2018 London, UK; 4^th Health Economics, Health Policy and Health care Management September 13-14, 2018 Zurich, Switzerland; 13^th Healthcare & Technologies Conferences June 14-15, 2018 Dublin, Ireland; 2^nd Patient Safety and Quality Healthcare June 21-22, 2018 Dublin, Ireland; 6^th Medical Informatics and Telemedicine Conferences July 5-6, 2018 Berlin, Germany; 3^rd Environmental Health Conferences October 15-16, 2018 Warsaw, Poland

Related Societies:

USA: American Association of Diabetes Educators | American Diabetes Association | Canadian Diabetes Association | American Association for Clinical Endocrinology | Diabetes Canada

Europe: European Society of Endocrinology | Central European Diabetes Association | FAND - Italian Association of Diabetics | Italian Association for the Defence of the Interests of Diabetics | International Diabetes Federation- Italy

Asia-Pacific: Australian Diabetes Society | Asian Association for the Study of Diabetes | Diabetes Association of Nigeria | Diabetes Association of the Republic of China | Asian Diabetic Association

Track-14: Case Reports and Others

Lipid disorders are a group of medical conditions which refer to excessive levels of fatty substances in the bloodstream. These fatty substances include cholesterol and triglycerides. An excess of bad cholesterol increases your risk of heart disease and stroke. A paraganglioma is rare neuroendocrine neoplasm that may develop at various body sites (including the head, neck, thorax and abdomen). About 97% are benign and cured by surgical removal; the remaining 3% are malignant neoplasm because they are able to produce distant metastases. "Paraganglioma" is now the most-widely accepted term for these lesions that have been also described as: glomus tumour, chemodectoma, perithelioma, fibroangioma, and congenital nevi. Metabolic disorders of bone strength, usually caused by abnormalities of minerals (such as calcium or phosphorus), vitamin D, bone mass or bone structure. The most common metabolic bone disorder is osteoporosis.

“27^th European Diabetes Congress” is going to be held during June 20-21, 2018 Rome, Italy. The Conference will be organized around the theme “New recommendations and practical approaches in the field of Diabetes as well as Endocrine disorders” highlighting the latest and exciting innovations in Diabetes Disease& Treatment. Diabetes 2018 Conference invites all Academic Scientists, Leading Endocrinologists, Surgeons, Oncologists, Radiation Therapists, General Physicians, Dieticians, Primary Health care specialists, Internists, Pharmaceutical Industrial Delegates, talented young scientists, and student communities across the globe to attend European Diabetes conference under a single roof where networking and global partnering happens for the acceleration of future research.

Today’s Market Study of Diabetes in USA | Europe | Middle East | Asia Pacific

Europe: The number of people living with diabetes in Europe is expected to increase from 52 million in 2014 to 68.9 million by 2035, according to the International Diabetes Federation (IDF). Across Europe, around 1 in 11 adults is affected and this number is set to rise as the population ages.

USA: Diabetes Mellitus has been growing at an exponential rate and World Health Organization (WHO) estimates that the diabetic population is likely to reach 366 million in 2030. The United States is expected to have an increase of 102 per cent in the diabetic epidemic in 2030 when compared to 2000

Middle East: The rate of diabetes in parts of the Arabian Peninsula is over twice the global average rate, and much higher than some other areas of the Middle East and North Africa (MENA). And cases of type-2 diabetes outnumber cases of type-1 diabetes by a ratio of 10:1.

Asia Pacific: The Asia-Pacific Diabetes Care Devices Market has been estimated at USD 2.461 Billion in 2015 and is projected to reach USD 3.518 billion by 2020, at a CAGR of 7.41% during the forecast period from 2015 to 2020.

For more details please visit- http://www.diabetesexpo.com/europe/

Conference Highlights:

• Diabetes Research in Clinical Practice
• Diabetes mellitus type 1
• Diabetes mellitus type 2
• Diabetic Disorders and Treatment
• Diabetes Advanced Technologies
• Gestational Diabetes
• Stem Cell treatment in Diabetes
• Diabetes Ophthalmology
• Endocrinology & Diabetes: Diseases & Disorders
• Thyroid Disorders in Children, Teens and Adolescents
• Advances in Endocrinology Metabolism
• Treatment and Diagnosis of Endocrine Diseases

Importance & Scope

Millions of people are suffering and also trying all kinds of diets, pills, and treatments to clear their mental fog, to boost energy and lose weight. Unfortunately, they will all fail unless they learn how to heal the underlying Diabetes issues.

Number of people suffering from Diabetes disorders & continues to rise each year. As reported by the World Health Organization (WHO), on an average 1 out of every 13 people more specifically 20 million to 750 million cases are diagnosed globally with Diabetes diseases each year. There are more than 250 million cases with Obesity globally. Around 60% of the populations effected with Diabetes disorder are uncaring of the situation. Male & Female population is 5-6 times more likely to develop a Diabetes disorder.

Many International Conferences meetings/ symposium and workshops have been organized on different topics related to the risk factors related to diabetes across the globe such as obesity conferences, weight loss conferences, Endocrine Conferences etc.

Conference Series Cordially invites all the Academic Scientists, Leading Endocrinologists, Diabetologists, Pediatricians, Surgeons, General Physicians, Dieticians, Primary Health care specialists, Internists, Pharmaceutical Industrial Delegates, talented young scientists, and student communities across the globe to attend European Diabetes Conference, where all the aspects of Diabetes Disorders and Treatment will be discussed under single roof. Diabetes 2018 will be an excellent amalgamation of academia and industry as it involves every aspects of empirical and conceptual thinking in exploring new dimensions in this field.  It is open to all types of research methodologies both from academia and industry.

Diabetes 2018 is an international platform for presenting research about Diabetes significance, Disorders & Treatment, exchanging ideas about it and thus, contributes to the dissemination of knowledge in management of the disease for the benefit of the society.

Why Italy?

The prevalence of diabetes as well as glucose intolerance is greater in men and in the regions of the Center and South of Italy. The prevalence of diabetes has doubled in Italy over the past decade and now affects about 3 million people. In Italy, the prevalence of diabetes is 6.6% among people over 20 years old, The Italian Ministry of Health estimates that the number of total undiagnosed cases of diabetes is approximately 2 million. By 2013, the number of cases of both type 1 and type 2 are expected to rise to about 2.7 million and 4 million, respectively. Current diabetes incidence ranges from 4 to 10 new cases per 100,000 inhabitants annually throughout most of the country, but is as high as 35 new cases per 100,000 in Sardinia. Approximately 15,000 new cases of type 1 diabetes and 185,000 new cases of type 2 diabetes are diagnosed nationwide each year, resulting in a and a type 1:type 2 ratio of 1:9. One recent study by the Associazione Medici Diabetologi (AMD, the Italian Association of Diabetes Doctors) found that the number of cases of both type 1 and type 2 diabetes is increasing at about 1% and 7-10% per year, likely due in part to improved screening measures and an increase in obesity and sedentary lifestyles. Reflecting this imperative Euro Diabetes 2018 aims to educate pediatricians and achieve the goal of reducing infant mortality rate.

Why to attend ???

Medical doctors, patients and health care providers consider the prevention of Diabetes diseases as an essential tool to improve the general health status of the population. The proportions of people suffering from the disease are expected to increase in future according a recent statistical survey. Realizing this imperative, Conference Series is set to organize 27th European Diabetes Congress for the upcoming year with a view to enhance research and promote awareness aiming in developing solutions for the challenges encountered.

Diabetes-2018 conference is comprised of 11 tracks designed to offer sessions including anatomy & physiology of diabetes, acute & chronic complication, Bio-marker: diagnostic tools for diabetes, emerging focus on diabetes research,   Advanced Technologies For The Treatment Of Diabetes, Diabetes & Insulin Medication, Integrated Physiology/Obesity, Diabetes & Metabolic Syndrome, Computational Biology Of Diabetes, Transplantation/immunology, Diabetes Medication & Therapy.

Members Associated with Diabetes Research

The American Diabetes Association (ADA) serves as the professional for all the leading researchers and clinicians and also for the people in the field of Diabetes, and provides a rich resource for the public and patients with Diabetes disease and Obesity. 1700 members from 43 different countries, working together in the organization of Researchers , Clinicians, Surgeons,  and other Healthcare professionals, to advance the care and treatment of patients with Diabetes disease. Also to inspire, educate, apprise and train registered medical practitioners, dieticians, qualified nurses and other appropriately qualified paramedical personnel in the field of Diabetes various well-known societies/associations are working across the world to professionally avoid and combat the lethal disease.

Societies Associated with Diabetes Research

FAND - Italian Association of Diabetics

Italian Association for the Defence of the Interests of Diabetics

Association of Diabetes

Association National Italian Diabetic Athletes

Italian Society of Diabetology

International Diabetes Federation- Italy

Primary Care Diabetes Society

Australian Diabetes Society

Emirates Diabetes Society

Society for Biomedical Diabetes Research

Immunology of Diabetes Society

American Association of Diabetes Educators

American Diabetes Association

The Asian Association for the Study of Diabetes

International Association of the Diabetes and Pregnancy Study Groups

Diabetes Association of Nigeria

Association of Children's Diabetes Clinicians

Canadian Diabetes Association

Target Audience:-

Euro Diabetes 2018 conference gathers renowned scientists, physicians, surgeons, young researchers, industrial delegates and talented student communities in the field of Thyroid under a single roof where networking and global partnering happens for the acceleration of future research. Following are the areas for targeting the audience percentage wise:

Scientists      60%

Academia    40%

Doctors       10%

Market Analysis on Diabetes

Diabetes industry guides to the 11 largest pharmaceutical and diagnostic companies producing diabetes related products or those involved with diabetes research. Diabetes is a major problem in the UK, and as such a large healthcare and treatment industry has built up around it .Diabetes care devices market is estimated to grow at a CAGR of 6.3% from 2015 to 2020, to reach USD 2.3 Billion by 2020 from USD 1.7 Billion in 2015. Factors such as increasing number of diabetic patients across BRIC countries, growing research on diabetes, and increasing international research collaborations are driving the growth of the this market. Rising obese population and lifestyle changes (driving the prevalence of diabetes among the urban population) are further contributing to the growth of this market. However, high cost of diabetes care devices, disparity in reimbursement, availability of alternative treatments, and lack of awareness are restraining the growth of this market.

Global Prevelance of Diabetes

One in 10 people globally will have diabetes by 2035, according to a concerning new report. To highlight World Diabetes Day which takes place each year on Nov. 14, the International Diabetes Federation (IDF) released its sixth edition of the Diabetes Atlas. The report estimates how many adults between the ages of 20 to 79 will be affected by the disease in the future. By the end of this year, the IDF estimates that 382 million people will have diabetes around the world. By 2035, that number will skyrocket to 592 million. For comparison, about 285 million people had the disease just four years ago. Eighty percent of people with the disease live in low- and middle-income countries, and most of them are between 40 and 59 years old. The organization also said that one person dies from diabetes every six seconds, or about 5.1 million deaths annually.

DISCLAIMER 

The information developed in this report is intended only for the purpose of understanding the scope of hosting related international meetings at the respective locations. This information does not constitute managerial, legal or accounting advice, nor should it be considered as a corporate policy guide, laboratory manual or an endorsement of any product, as much of the information is speculative in nature. Conference Organizers take no responsibility for any loss or damage that might result from reliance on the reported information or from its use.